H-77
H-77 is a selective Renin inhibitor with an IC50 of 1.2 μM. H-77 causes dose-dependent decreases in plasma angiotensin I, plasma angiotensin II, and mean arterial pressure in sodium-depleted conscious beagle dogs. H-77 does not alter blood pressure or plasma angiotensin II levels in conscious chronically cannulated rats. H-77 can be used in studies related to the physiological and pathological states of the renin-angiotensin system.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 82131-82-6
- Fòrmula: C52H74N12O9
- Peso molecular:1011.24
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
H-77 (1.0-10.0 mg/kg; intravenous injection) does not significantly alter the mean arterial pressure or plasma angiotensin II concentration in conscious, unrestrained female Wistar rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Beagle (male, 12.7-18 kg, sodium-depleted hypertension model)[1]
-
Dosage:0.01 mg·kg-1·hr-1; 0.1 mg·kg-1·hr-1; 1.0 mg·kg-1·hr-1; 10.0 mg·kg-1·hr-1
-
Administration:i.v.; 30 minutes (0.01, 1.0, 10.0 mg·kg-1·hr-1); 4 hours (0.1 mg·kg-1·hr-1)
-
Result:Reduced circulating angiotensin I and angiotensin II concentrations within 15 minutes, with effects persisting through the 4-hour infusion, and lowered mean arterial pressure at 0.1 mg·kg-1·hr-1.
Markedly reduced plasma angiotensin I and angiotensin II concentrations, with significant decreases relative to control (p < 0.01 to p < 0.001) at 1.0 and 10.0 mg·kg-1·hr-1.
Produced greater, more persistent reductions in mean arterial pressure, with heart rate increasing significantly during marked hypotension from the 10.0 mg·kg-1·hr-1 dose.
Had little effect on angiotensin levels or blood pressure at 0.01 mg·kg-1·hr-1.
Correlated significantly between changes in plasma angiotensin II concentration and changes in angiotensin I concentration (r = 0.72-0.77, p < 0.001) and mean arterial pressure (r = 0.69-0.72, p < 0.001).
Chemical Information
-
No. CAS 82131-82-6
-
Peso molecular 1011.24
-
Fòrmula C52H74N12O9
-
SMILES
C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC2=CN=CN2)C(N[C@H](CN[C@H](C(N[C@H](C(N[C@@H](CC3=CC=C(O)C=C3)C(O)=O)=O)C(C)C)=O)CC(C)C)CC(C)C)=O)=O)(=O)[C@H]4N(C([C@@H](CC5=CN=CN5)N)=O)CCC4
-
Sequence
His-Pro-Phe-His-{Leu(CH2-NH)}-Leu-Val-Tyr
-
Sequence Shortening
HPFH-{Leu(CH2-NH)}-LVY
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Szelke M, et al. H-77: a potent new renin inhibitor. In vitro and in vivo studies. Hypertension (Dallas, Tex. : 1979). 1982;4(3 Pt 2):59-69. [Content Brief]
[2]. LECKIE B J, et al. Human renin inhibitors[J]. 1985.
[3]. McIntyre GD, et al. Purification of human renin by affinity chromatography using a new peptide inhibitor of renin, H.77 (D-His-Pro-Phe-His-LeuR-Leu-Val-Tyr). Biochem J. 1983 May 1;211(2):519-22. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)